Market Overview

Emergent BioSolutions Names Robert G. Kramer CFO


Emergent BioSolutions (NYSE: EBS) today announced that Robert G. Kramer
has been appointed as the company's chief financial officer effective
December 3, 2012. Mr. Kramer succeeds R. Don Elsey, who will be leaving
to pursue a new opportunity at a private healthcare company. Mr. Kramer
is currently executive vice president, corporate services division, and
with this appointment, his title will become executive vice president,
corporate services division and chief financial officer, reporting
directly to Daniel J. Abdun-Nabi, Emergent's president and chief
executive officer.

“Bob has been a major part of Emergent's success through the years and
has been intimately involved in the development of our recently
announced growth plan. Together, we look forward to achieving

See full press release

Posted-In: News Guidance Management


Related Articles (EBS)

View Comments and Join the Discussion!